LEIGH ANNE HARVEY: Open Payments
NPI 1265598395 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 21 payments from 9 companies in 2025. Trend: 2023 $652 · 2024 $277 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $107 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Alkermes, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Luye Pharma (USA) Ltd. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, INGREZZA, ARISTADA, INVEGA SUSTENNA, CAPLYTA, ERZOFRI EXTENDED-RELEASE, COBENFY, UZEDY.
Industry payments across GA — which companies pay providers there.
